Intellia Therapeutics on Monday revealed new evidence that an infusion of a CRISPR gene editing medicine into the body could treat a rare inherited illness, bolstering earlier study results that were viewed as a landmark moment for the Nobel Prize-winning technology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,